Where The Risk Is Least

Biotech tracking fund IBB, has posted itself into an interesting position.

Last week, it launched higher over +7% and penetrated long established resistance; this week, it has essentially stopped dead.

Biotech IBB, Weekly

If what we have is the repeating pattern of ‘spring-to-up-thrust’, it’s happening on a massive scale.

For a short position, the broker being used indicates HTB (Hard To Borrow); there are potential fees associated with selling short.

With that said, the 2X leveraged Inverse fund is BIS. However, it too has problems. It’s not liquid; typically, 14K – 20K shares a day.

Nonetheless, short established via BIS (BIS-25-01) with stop at the week’s low of 11.95 (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279